The acquisition positions TraceLink as the only end-to-end platform enabling life sciences companies to capture, process and exchange serialised product data across a digital supply chain network, while also more effectively managing warehouse product inventory at the edge of the supply chain.
Shabbir Dahod, President and CEO at TraceLink, said: “This acquisition further widens our leadership position by seamlessly merging best-of-breed serialisation capabilities into a comprehensive solution set that no other provider can offer.
"As a result, we will be able to serve broader serialisation challenges in the pharmaceutical industry as well as explore new capabilities for real-time information sharing that support the longer-term business and patient safety goals of our customers.”
By acquiring ROC IT and integrating EdgeTRAC into its family of serialisation software, TraceLink now offers solutions for serialised receiving, picking, shipping, returns, deactivation, aggregation, de-aggregation, label printing and tag management of pharmaceutical products.
The acquisition also increases TraceLink’s physical presence in the US, bringing the total number of locations to two, including its global headquarters in North Reading, MA and a new office in Pittsford, NY.
Larry Hall, Co-Founder and Vice President of Sales and Operations of ROC IT, said: “By joining forces with TraceLink, we have aligned ourselves with the winning team to build an even stronger collaboration to propel the industry forward. We look forward to this next chapter with TraceLink and ensuring the ongoing success of our customers, partners and team by leveraging TraceLink’s industry expertise, proven solutions and global customer success."
